Company Profiles

driven by the PitchBook Platform

Apellis

Description

Developer of novel therapeutics and drug delivery technologies. The company develops peptide drugs focused on the immunology space such as asthma and chronic obstructive pulmonary disease.

2009

Founded

PRIVATE

Status

11-50

Employees

Series D

Latest Deal Type

$47.1M

Latest Deal Amount

$95.5M

Total Amount Raised

Description

Developer of novel therapeutics and drug delivery technologies. The company develops peptide drugs focused on the immunology space such as asthma and chronic obstructive pulmonary disease.

Website:

www.apellis.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Biotechnology
Drug Delivery

Primary Office

6400 Westwind Way Suite A Crestwood, KY 40014United States +1 (502) 241-4114
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Apellis's full profile, request a free trial.

    Apellis Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Apellis Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    Apellis Investors (11)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    AJU IB InvestmentVenture CapitalMinority000 0000000 0000
    Cormorant Asset ManagementHedge FundMinority000 0000000 0000
    Epidarex CapitalVenture CapitalMinority000 0000000 0000
    HealthCare VenturesVenture CapitalMinority000 0000000 0000
    Hillhouse Capital GroupVenture CapitalMinority000 0000000 0000
    AJU IB Investment Venture Capital
    Cormorant Asset Management Hedge Fund
    Epidarex Capital Venture Capital
    HealthCare Ventures Venture Capital
    Hillhouse Capital Group Venture Capital

    Apellis Executive Team (13)

    NameTitleBoard
    Seat
    Contact
    Info
    Mike Yeadon Ph.DConsultant (Acting Chief Scientific Officer)
    Candace DeppProject Manager & Co-Founder
    David Watson JDVice President, Corporate Development & General Counsel
    Federico Grossi Ph.DVice President, Clinical Development
    Nicole PerryVice President, Finance
    Mike Yeadon Ph.D Consultant (Acting Chief Scientific Officer)
    Candace Depp Project Manager & Co-Founder
    David Watson JD Vice President, Corporate Development & General Counsel
    Federico Grossi Ph.D Vice President, Clinical Development
    Nicole Perry Vice President, Finance

    Apellis Board Members (9)

    NameRepresentingRoleSinceContact
    Info
    Alec MachielsPegasus Capital AdvisorsPartner000 0000
    Bihua ChenCormorant Asset ManagementFounder, Chief Executive Officer & Portfolio Manager000 0000
    Cedric Francois Ph.DSelfChief Executive Officer, Board Member, President & Co-Founder000 0000
    David DarstSelfBoard Member & Co-Founder000 0000
    Gerald Chan Ph.DMorningside GroupCo-Founder & Chairman000 0000
    Alec Machiels Partner Pegasus Capital Advisors
    Bihua Chen Founder, Chief Executive Officer & Portfolio Manager Cormorant Asset Management
    Cedric Francois Ph.D Chief Executive Officer, Board Member, President & Co-Founder Self
    David Darst Board Member & Co-Founder Self
    Gerald Chan Ph.D Co-Founder & Chairman Morningside Group
    Request full access to PitchBook